secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonnet BioTherapeutics Holdings, Inc. (—)
CIK:        0001106838
Form:       8-K
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0001493152-23-045057
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonnet BioTherapeutics gets Nasdaq delisting notice; stockholders' equity negative $226K
--------------------------------------------------------------------------------

- Nasdaq notified Sonnet on Dec 15, 2023 of non-compliance with $2.5M minimum stockholders' equity requirement.
- Stockholders' equity reported at ($225,980) as of Sept 30, 2023, below the continued listing standard.
- Company has 45 calendar days (by Jan 29, 2024) to submit a plan to regain compliance to Nasdaq.
- If plan accepted, Nasdaq may grant up to 180 days from notice date to evidence compliance.
- Failure to regain compliance could result in delisting from Nasdaq Capital Market, harming liquidity and capital access.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106838/000149315223045057/0001493152-23-045057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106838/000149315223045057/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-045057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer